09:42 AM EDT, 05/24/2024 (MT Newswires) -- Stereotaxis ( STXS ) said Friday it received CE Mark recertification under the European Union's new Medical Device Regulation framework, covering all of the company's available devices in Europe.

The company said the new framework replaces the former European Medical Device Directive for the approval and marketing of medical devices in the EU and its CE Mark recertification will support the regulatory processes for its future innovations.

Price: 2.03, Change: +0.01, Percent Change: +0.50